Abstract
The widespread use of indwelling medical devices has enormously increased the interest in materials incorporating antibiotics and antimicrobial agents as a means to prevent dangerous device-related infections. Recently, chlorhexidine-loaded polyurethane has been proposed as a material suitable for the production of devices which are able to resist microbial contamination. The aim of the present study was to characterize the in vitro release of chlorhexidine from new polymeric orthodontic chains realized with polyurethane loaded with two different chlorhexidine salts: chlorhexidine diacetate or chlorhexidine digluconate. The orthodontic chains constituted of three layers: a middle polyurethane layer loaded with chlorhexidine salt inserted between two layers of unloaded polymer. In vitro release of chlorhexidine diacetate and digluconate from orthodontic chains loaded with 10% or 20% (w/w) chlorhexidine salt was sustained for 42 days and followed Fickian diffusion. The drug diffusion through the polyurethane was found to be dependent not only on chlorhexidine loading, but also on the type of chlorhexidine salt. The antibacterial activity of 0.2% (w/w) chlorhexidine diacetate-loaded orthodontic chain was successfully tested towards clinically isolated biofilm forming ica-positive Staphylococcus epidermidis via agar diffusion test. In conclusion, the chlorhexidine salt-loaded chains could provide an innovative approach in the prevention of oral infections related to the use of orthodontic devices.
Similar content being viewed by others
REFERENCES
Chauvel-Lebert DJ, Auroy P, Bonnaure-Mallet M. Biocompatibility of elastomers. In: Dumitriu S, editor. Polymeric biomaterials. New-York: Marcel Dekker; 2002. p. 311–60.
Eliades T. Orthodontic materials research and applications: part 2. Current status and projected future developments in materials and biocompatibility. Am J Orthod Dentofac Orthop. 2007;131(2):253–62. doi:10.1016/j.ajodo.2005.12.029.
Renick MR, Brantley WA, Beck FM, Vig KWL, Webb CS. Studies of orthodontic elastomeric modules. Part 1: glass transition temperatures for representative pigmented products in the as-received condition and after orthodontic use. Am J Orthod Dentofac Orthop. 2004;126(3):337–43. doi:10.1016/j.ajodo.2003.07.017.
Opsahl Vital S, Haignere-Rubinstein C, Lasfargues J-J, Chaussain C. Caries risk and orthodontic treatment. Int Orthod. 2010;8(1):28–45. doi:10.1016/j.ortho.2009.12.003.
Jones CG. Periodontology 2000. Periodontology. 1997;15(1):55–62. doi:10.1111/j.1600-0757.1997.tb00105.x.
Reverdy ME. La chlorhexidine. In: Fleurette J, Freney J, Reverdy ME, editors. Antisepsie et désinfection. Paris: ESKA; 1995. p. 135–68.
Becerik S, Turkoglu OYA, Emingil G, Vural C, Özdemir G, Atilla G. Antimicrobial effect of adjunctive use of chlorhexidine mouthrinse in untreated gingivitis: a randomized, placebo-controlled study. APMIS. 2011;119(6):364–72. doi:10.1111/j.1600-0463.2011.02741.x.
Menegon RF, Blau L, Janzantti NS, Pizzolitto AC, Corrêa MA, Monteiro M, et al. A nonstaining and tasteless hydrophobic salt of chlorhexidine. J Pharm Sci. 2011;100(8):3130–8. doi:10.1002/jps.22517.
Stanislawczuk R, Reis A, Loguercio AD. A 2-year in vitro evaluation of a chlorhexidine-containing acid on the durability of resin-dentin interfaces. J Dent. 2011;39(1):40–7. doi:10.1016/j.jdent.2010.10.001.
Verraedt E, Pendela M, Adams E, Hoogmartens J, Martens JA. Controlled release of chlorhexidine from amorphous microporous silica. J Control Release. 2010;142(1):47–52. doi:10.1016/j.jconrel.2009.09.022.
Verraedt E, Braem A, Chaudhari A, Thevissen K, Adams E, Van Mellaert L, et al. Controlled release of chlorhexidine antiseptic from microporous amorphous silica applied in open porosity of an implant surface. Int J Pharm. 2011;419(1–2):28–32. doi:10.1016/j.ijpharm.2011.06.053.
Fong N, Simmons A, Poole-Warren LA. Antibacterial polyurethane nanocomposites using chlorhexidine diacetate as an organic modifier. Acta Biomater. 2010;6(7):2554–61. doi:10.1016/j.actbio.2010.01.005.
Huynh TTN, Padois K, Sonvico F, Rossi A, Zani F, Pirot F, et al. Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate. Eur J Pharm Biopharm. 2010;74(2):255–64. doi:10.1016/j.ejpb.2009.11.002.
Catalbas B, Ercan E, Dalli M, Gelgor IE, Erdemir A. Does chlorhexidine affect the shear bond strengths of orthodontic brackets? J Dent Sci. 2011;6(2):76–81. doi:10.1016/j.jds.2011.04.002.
Dalli M, Ercan E, Zorba YO, Ince B, Sahbaz C, Bahsi E, et al. Effect of 1% chlorhexidine gel on the bonding strength to dentin. J Dent Sci. 2010;5(1):8–13. doi:10.1016/s1991-7902(10)60002-5.
Eliades T, Eliades G, Watts DC, Brantley WA. Elastomeric ligatures and chains. In: W.A. Brantley, T. Eliades (eds.) Elsevier, New-York 2001
Langlade M. Force élastique de classe 1, Optimisation des élastiques orthodontiques. Maloine ed. Paris 2000.
Lboutounne H, Chaulet J-F, Ploton C, Falson F, Pirot F. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly([ε]-caprolactone) nanocapsule encapsulated form and as a digluconate. J Control Release. 2002;82(2–3):319–34. doi:10.1016/s0168-3659(02)00142-6.
Nerurkar MJ, Zentner GM, Rytting JH. Effect of chloride on the release of chlorhexidine salts from methyl methacrylate: 2-hydroxyethyl methacrylate copolymer reservoir devices. J Control Release. 1995;33(3):357–63. doi:10.1016/0168-3659(94)00104-3.
Zeng P, Rao A, Wiedmann TS, Bowles W. Solubility properties of chlorhexidine salts. Drug Dev Ind Pharm. 2009;35(2):172–6. doi:doi:10.1080/03639040802220318.
Zeng P, Zhang G, Rao A, Bowles W, Wiedmann TS. Concentration dependent aggregation properties of chlorhexidine salts. Int J Pharm. 2009;367(1–2):73–8. doi:10.1016/j.ijpharm.2008.09.031.
Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev. 2001;48(2–3):229–47. doi:10.1016/s0169-409x(01)00116-8.
Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2–3):139–57. doi:10.1016/s0169-409x(01)00112-0.
Hiraishi N, Yiu CKY, King NM, Tay FR, Pashley DH. Chlorhexidine release and water sorption characteristics of chlorhexidine-incorporated hydrophobic/hydrophilic resins. Dent Mater. 2008;24(10):1391–9. doi:10.1016/j.dental.2008.03.011.
Martinelli A, D’Ilario L, Francolini I, Piozzi A. Water state effect on drug release from an antibiotic loaded polyurethane matrix containing albumin nanoparticles. Int J Pharm. 2011;407(1–2):197–206. doi:10.1016/j.ijpharm.2011.01.029.
Schneider NS, Illinger JL, Karasz FE. Effect of water on the glass transition temperature of hydrophilic polyurethanes. J Appl Polym Sci. 1993;48(10):1723–9. doi:10.1002/app.1993.070481005.
Farkas E, Zelkó R, Török G, Rácz I, Marton S. Influence of chlorhexidine species on the liquid crystalline structure of vehicle. Int J Pharm. 2001;213(1–2):1–5. doi:10.1016/s0378-5173(00)00575-5.
Cafiso V, Bertuccio T, Santagati M, Campanile F, Amicosante G, Perilli MG, et al. Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production. Clin Microbiol Infect. 2004;10(12):1081–8. doi:10.1111/j.1469-0691.2004.01024.x.
Kalaga A, Addy M, Hunter B. Comparison of chlorhexidine delivery by mouthwash and spray on plaque accumulation. J Periodontol. 1989;60:127–30.
Jenkins S, Addy M, Newcombe RG. Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol. 1994;21:250–5.
McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA, Pier GB. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 1998;66(10):4711–20.
von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs. 2005;65(2):179–214.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Padois, K., Bertholle, V., Pirot, F. et al. Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies. AAPS PharmSciTech 13, 1446–1450 (2012). https://doi.org/10.1208/s12249-012-9872-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-012-9872-6